Related Experiment Video
Updated: Mar 16, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Recent "omics" advances in Helicobacter pylori
Elvire Berthenet1, Sam Sheppard2, Filipa F Vale3
1College of Medicine, Institute of Life Science, Swansea University, Swansea, UK.
High-throughput whole genome sequencing (WGS) advances microbiology, enabling detailed Helicobacter pylori studies. Omics research is enhancing our understanding of H. pylori biology, diversity, and pathogenesis.
Area of Science:
- Microbiology
- Genomics
- Pathogen Biology
Background:
- High-throughput whole genome sequencing (WGS) technologies are revolutionizing microbiology.
- Comparing numerous genomes from different lineages of the same organism is now feasible.
- Helicobacter pylori is a significant human pathogen with complex biology and diversity.
Purpose of the Study:
- To review recent advances in Helicobacter pylori "omics" research.
- To understand how "omics" data improve knowledge of H. pylori biology, diversity, and pathogenesis.
- To assess the impact of "omics" on H. pylori research and its potential clinical applications.
Main Methods:
- Literature review focusing on works published between April 2015 and March 2016.
- Analysis of advances in "omics" technologies applied to H. pylori.
- Examination of the growing number of H. pylori genomes in public archives (510 deposited since 1997).
Main Results:
- WGS technologies facilitate large-scale genome comparisons within H. pylori.
- "Omics" approaches are significantly improving the understanding of H. pylori epidemiology and evolution.
- The field of Helicobacter "omics" is rapidly expanding and demonstrating a substantial impact.
Conclusions:
- Helicobacter pylori "omics" research is a dynamic and impactful field.
- Advances in "omics" are crucial for deciphering H. pylori biology, diversity, and pathogenesis.
- Future translation of "omics" findings into clinical settings holds promise for improving public health.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Modern Molecular Taxonomy
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...

